Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Return on Capital Employed: 2018-2025

Historic Return on Capital Employed for Arcus Biosciences (RCUS) over the last 8 years, with Sep 2025 value amounting to -0.47%.

  • Arcus Biosciences' Return on Capital Employed fell 17.00% to -0.47% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.47%, marking a year-over-year decrease of 17.00%. This contributed to the annual value of -0.37% for FY2024, which is 3.00% down from last year.
  • Arcus Biosciences' Return on Capital Employed amounted to -0.47% in Q3 2025, which was down 27.25% from -0.37% recorded in Q2 2025.
  • Arcus Biosciences' Return on Capital Employed's 5-year high stood at 0.06% during Q3 2022, with a 5-year trough of -0.47% in Q3 2025.
  • In the last 3 years, Arcus Biosciences' Return on Capital Employed had a median value of -0.32% in 2023 and averaged -0.34%.
  • In the last 5 years, Arcus Biosciences' Return on Capital Employed surged by 44bps in 2022 and then crashed by 38bps in 2023.
  • Over the past 5 years, Arcus Biosciences' Return on Capital Employed (Quarterly) stood at 0.05% in 2021, then decreased by 29bps to -0.24% in 2022, then fell by 11bps to -0.35% in 2023, then increased by 2bps to -0.33% in 2024, then dropped by 17bps to -0.47% in 2025.
  • Its Return on Capital Employed stands at -0.47% for Q3 2025, versus -0.37% for Q2 2025 and -0.45% for Q1 2025.